维普中文期刊产品整合服务
24篇 您的检索式:作者名="Rubenstein EB"
    题名 作者 年代 出处 被引量
1The Multinational Association for Supportive Care in Cancer risk index: A multinational scoring system for identifying low - risk febrile neutropenic cancer patients 显示文摘Klastersky J Paesmans M Rubenstein EB 2000J Clin Oncol2000,18,:1
2Mississippi mad in the 1990s: Risks and outcomes of vancomycin-asso- ciated toxicity in general oncology practice 显示文摘Elting ES Rubenstein EB Kurtin D 1998Cancer1998,83,12:1
3clinical practice guidelines for the prevention and treatment of cancer therapy-induced oral and gastrointestinal mucositis显示文摘Rubenstein EB Peterson DE Schubert M 2004Cancer2004,100,9:1
4Pharmacoeconomic analysis of oprelvekin (recombinant human interleukin- 11) for secondary prophylaxis of thrombocytopenia in solid tumor patients receiving chemotherapy 显示文摘Cantor SB Ehing LS Rubenstein EB 2003Cancer2003,97,12:1
5The Muhi- national Association for Supportive Care in Cancer risk in- dex:A multinational scoring system for identifying low-risk febrile neutropenic cancer patients 显示文摘Klastersky J Paesmans M Rubenstein EB 2000J Clin Oncol2000,18,16:1
6Measuring chem- otherapy-induced nausea and emesis - Psychometric prop- erties of a quality of life questionnaire显示文摘Martin CG Rubenstein EB Elting LS 2003Cancer2003,98,3:1
7Mississippi mud in the 1990s: risks and outcomes of vancomycin -associated toxicity in general oncology practice 显示文摘Ehing LS Rubenstein EB Kurtin D 1998Cancer1998,83,:1
8Clinical practice guidelines for the prevention and treatment of cancer therapy-induced oral and gastrointestinal mucositis 显示文摘Rubenstein EB Peterson DE Schubert M 2004Cancer2004,,:1
9Clinical practice guidelines for the prevention and treatment of cancer therapy-induced oral and gastrointestinal mucositis 显示文摘Rubenstein EB Peterson DE Schubert M 2004Cancer2004,100,9:1
10Mississippi mud in the 1990s: risks and outcomes of vancomycin-associated toxicity in general ontology practice显示文摘Elting LS Rubenstein EB Kurtin D 1998Cancer1998,83,12:1
11Palonosetron: A unique 5-HT (3) receptor antagonist indicated for the prevention of acute and delayed chemotherapy induced nausea and vomiting 显示文摘Rubenstein EB 2004Clin Adv HematolOncol2004,2,5:1
12Clinical practice guidelines for the prevention and treatment of cancer therapy- induced oral and gastrointestinal mucositis显示文摘Rubenstein EB Peterson DE Schubert M 2004Cancer2004,100,9:1
13The multinational association for supportive care in cancer risk index:a multinational scoring system for identifying low-risk febrile neutropenic cancer patients显示文摘Klatersky J Paesmans M Rubenstein EB 0,,06:1
14Mississippi mud in the 1990s: risks and outcomes of vancomycin-associ- ated toxicity in general oncology practice显示文摘Ehing LS Rubenstein EB Kurtin D 1998Cancer1998,83,12:1
15Ciprofloxacin-induced nephrotoxicity in patients with cancer显示文摘Lo WK Rolston KV Rubenstein EB 1993Arch Intern Med1993,153,10:1
16Palonosetron: a unique 5-HT3 receptorantagonist indicated for the prevention of acute and de-layed chemotherapy-induced nausea and vomiting显示文摘Rubenstein EB 2004ClinAdv Hematol Oncol2004,2,5:1
17Measuring chemotherapy-in- duced nausea and emesis显示文摘Martin CG Rubenstein EB Elting LS 2003Cancer2003,98,3:1
18Mississippi mud in the 1990s:risks and outcomes of vancomycin-associated toxicity in general oncology practice显示文摘Elting LS Rubenstein EB Kurtin D 1998Cancer1998,83,:1
19Clinical practice guidelines for the prevention and treatment of cancer therapy - in- duced oral and gastrointestinal mucositis 显示文摘Rubenstein EB Peterson DE Schubert M 2004Cancer2004,100,9:1
20Palonosetron : a unique 5-HT(3) receptor antagonist indicated for the prevention of acute and delayed chemotherapy-induced nausea and vomiting 显示文摘RUBENSTEIN EB 2004Clin Adv Hematol Oncol2004,2,5:1
返回顶部 每页显示:
共2页 首页 上一页 第1页 下一页 末页 /2 跳转

网站首页 | 关于我们 | 联系我们 | 产品服务 | 客服中心 | 广告服务 | 版权声明 | 网站联盟 | 友情链接 | 售卡网点

版权所有© 渝B2-20050021-1 渝公网安备 50019002500403号 违法和不良信息举报中心

互联网出版许可证 新出网证(渝)字10号 全国400电话 - 免长途话费